This week is the World Economic Forum Annual Meeting in Davos, gathering politicians, business and opinion leaders from all around the globe to discuss the most pressing issues facing the world. 1928 Diagnostics is one of the Technology Pioneers invited and our CEO, Kristina Lagerstedt, is attending the meeting.
As part of the Annual Meeting Kristina has written a blog post on one of the pressing issues discussed at the meeting: How to win the war against antibiotic resistant bacteria.
Antibiotic Resistance is threatening the effectiveness of life-saving medications against bacterial infections. Today is the first day of the World Antibiotic Awareness Week. Let us join together to deal with this problem!
We are truly honoured that 1928 Diagnostics was awarded the Arvid Carlsson Award 2018. The award was received by the founders Kristina Lagerstedt and Susanne Staaf at the 13th Park Annual on the theme “A brand new world”. 1928 Diagnostics will continue to fight antibiotic resistance with powerful technology and a strong determination to improve world health.
1928 Diagnostic’s CEO recently came back from the WEF-conference Annual Meeting of the New Champions where we were awarded Technology Pioneer of 2018. It is an honour to attend this exciting event in Tianjin, China Sept 17th-21st. Amazing to meet so many incredible and inspiring people e.g. Matt Hancock, UK Secretary of state for Health and Social Care, who gave an insightful talk at the healthcare systems of tomorrow session.
1928 Diagnostics, Gothenburg-based Swedish company was selected when World Economic Forum on Thursday announced its selection of the world’s 61 most promising Technology Pioneers 2018, the most diverse class of such pioneers ever. Companies were selected for their potential to “transform society and industry” and “shape the Fourth Industrial Revolution,” Fulvia Montresor of the World Economic Forum said.
Antibiotic resistance is a major threat against humanity and 1928 Diagnostics’ contribution to fight antibiotic resistance is their powerful and fully automated platform for analysis of the complete genetic code of bacteria. 1928 Diagnostics made it to the selection for its contributions in the field of Health.
-“We welcome 1928 Diagnostics in this diverse group of technology pioneers,” says Fulvia Montresor, Head of Technology Pioneers at the World Economic Forum. “1928 Diagnostics and its fellow pioneers are front and centre in shaping the ongoing Fourth Industrial Revolution and we believe they will be transforming society and industry in a positive way in the years to come.”
-“It’s a true honor to be acknowledged as a Tech pioneer by the World Economic Forum in this selection of impressive companies worldwide. The award encourages the 1928 Diagnostics team to work even harder to erase and/or bridge the gap between DNA technology and infection control, an effort that will ultimately save many lives. At the same time we want to use this opportunity to leverage the importance of global collaboration to save the power of antibiotics and fight antibiotic resistant bacteria – one of the greatest threats against humanity”, says CEO Kristina Lagerstedt of 1928 Diagnostics.
Click here to read the full press release.
Read about how 1928D is fighting antibiotic resistance in todays number of Göteborgs-Posten. (In Swedish)
1928D was selected as one of the 33 most innovative and promising companies in Sweden for the second time in a row. The list is published by Swedish leading technology magazine Ny teknik and the prominent Affärsvärlden, a leading economy publisher.
1928 Diagnostics was one of three finalists in the 2018 eHealth award. The award focuses on giving attention to Swedish innovations in digital health that can enable more efficient and safer processes in health care.
The 1928D team is in Madrid at ECCMID 2018. New and old customers, collaborators and friend are very welcome to meet us in booth 90!
1928DSA, our clinical decision support software for Staphylococcus aureus infections now has a CE mark (IVD, in vitro diagnostic device). We are happy that another step is taken to enable powerful diagnostics of MRSA infections by using whole genome sequencing. We are extremely proud over the hard work the whole 1928D development team has put in to reach this milestone and look forward to releasing new diagnostic products on the market.